Access to the PPM Journal and newsletters is FREE for clinicians.

CGRPs: Your Patients Want To Know More

August 14, 2018
A new survey shows that migraineurs are largely unaware of the new preventive medication class.

Migraine has become one of the most commonly discussed pain management topics this year, largely due to the emergence and approval of the first calcitonin gene-related peptide indicated to prevent the disease. Healthcare providers are still learning how and when to prescribe use this new class of medications, including by addressing a number of unanswered questions with regard to comorbidities and potential risks. Meanwhile, it seems that patients are still largely unaware that the CGRP product pipeline even exists.

According to a national survey  by Health Union, LLC, only one-third of approximately 4,350 respondents – all diagnosed with migraine – are aware of the new therapies. Of those surveyed, 79% said “they are at least ‘very likely’ to use them,” but more than half were not sure how CGRPs might be integrated into their treatment plans, according to a news release about the survey. Just over a 25% plan to add the CGRPs to their regimens, while 23% intend to replace one of their current medications with a CGRP.

While clinicians may be primarily concerned with long-term safety data and potential cardiovascular effects, patients in the survey expressed more concerns over CGRP affordability, availability, and coverage, as well as efficacy and potential adverse events.

According to the survey release, “low awareness levels of CGRP treatments among patients could be due to little information received from physicians about the new medications. Only 19% of those aware reported they found out about CGRPs via a healthcare professional.” Of note, the lack of patient awareness seems to extend beyond CGRP antagonists, as about 7 in 10 of the survey respondents said they were not aware of any new migraine treatments coming to market.

Considering sharing PPM’s Migraine Resource Center, including patient stories, the latest treatment approaches, and more with your patients. 



Last updated on: August 16, 2018
Continue Reading:
At Stake: The Possible Long-Term Side Effects of CGRP Antagonists
close X